Business Model StrengthThe company's diversified revenue streams, including subscriptions and consulting, provide a stable foundation for long-term growth and resilience against market fluctuations.

Balance Sheet HealthA strong balance sheet with low leverage enhances financial flexibility and reduces risk, supporting sustainable growth and investment capacity.

Operational EfficiencyConsistent operational efficiency, as indicated by stable margins, allows the company to maintain profitability and competitive positioning in the market.

Bears Say

Revenue DeclineA decline in revenue signals potential market challenges or competitive pressures, which could impact long-term growth and profitability.

Net Income DeclineDecreasing net income may indicate inefficiencies or increased costs, potentially affecting the company's ability to reinvest in growth and innovation.

Cash Flow ConcernsReduced free cash flow can limit the company's ability to fund operations, invest in new projects, and return value to shareholders, impacting long-term financial health.

GMO Research & AI,Inc. News

Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!

Earnings reports, economic data, deals, and more lead the biggest stock market stories for Wednesday! ...

6M ago

CRM

IBM

3695 FAQ

What was GMO Research & AI,Inc.’s price range in the past 12 months?

GMO Research & AI,Inc. lowest stock price was ¥1722.00 and its highest was ¥3130.00 in the past 12 months.

What is GMO Research & AI,Inc.’s market cap?

GMO Research & AI,Inc.’s market cap is ¥7.97B.

When is GMO Research & AI,Inc.’s upcoming earnings report date?

GMO Research & AI,Inc.’s upcoming earnings report date is May 12, 2026 which is in 83 days.

How were GMO Research & AI,Inc.’s earnings last quarter?

GMO Research & AI,Inc. released its earnings results on Feb 10, 2026. The company reported ¥14.35 earnings per share for the quarter, beating the consensus estimate of N/A by ¥14.35.

Is GMO Research & AI,Inc. overvalued?

According to Wall Street analysts GMO Research & AI,Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does GMO Research & AI,Inc. pay dividends?

GMO Research & AI,Inc. pays a Annually dividend of ¥34.58 which represents an annual dividend yield of 5.22%. See more information on GMO Research & AI,Inc. dividends here

What is GMO Research & AI,Inc.’s EPS estimate?

GMO Research & AI,Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does GMO Research & AI,Inc. have?

GMO Research & AI,Inc. has 4,446,357 shares outstanding.

What happened to GMO Research & AI,Inc.’s price movement after its last earnings report?

GMO Research & AI,Inc. reported an EPS of ¥14.35 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.049%.

Which hedge fund is a major shareholder of GMO Research & AI,Inc.?

Currently, no hedge funds are holding shares in JP:3695

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

GMO Research & AI,Inc.

GMO Research & AI, Inc. (3695) is a leading technology company specializing in market research and artificial intelligence solutions. The company operates primarily in the data analytics and consumer insights sectors, leveraging advanced AI algorithms to provide businesses with actionable insights derived from large data sets. Its core products include AI-driven survey platforms, data analytics tools, and consulting services aimed at enhancing decision-making processes for clients across various industries.